Increased T Cell Reactivity to Amyloid Beta Protein in Older Humans and Patients with Alzheimer Disease

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2003 Aug 5

PMID 12897209

Citations 146

Authors

Alon Monsonego

Victor Zota

Arnon Karni

Jeffery I Krieger

Amit Bar-Or

Gal Bitan

Andrew E Budson

Reisa Sperling

Dennis J Selkoe

Howard L Weiner

Affiliations

Soon will be listed here.

Abstract

Alzheimer disease (AD) is characterized by the progressive deposition of the 42-residue amyloid beta protein (Abeta) in brain regions serving memory and cognition. In animal models of AD, immunization with Abeta results in the clearance of Abeta deposits from the brain. However, a trial of vaccination with synthetic human Abeta1-42 in AD resulted in the development of meningoencephalitis in some patients. We measured cellular immune responses to Abeta in middle-aged and elderly healthy subjects and in patients with AD. A significantly higher proportion of healthy elderly subjects and patients with AD had strong Abeta-reactive T cell responses than occurred in middle-aged adults. The immunodominant Abeta epitopes in humans resided in amino acids 16-33. Epitope mapping enabled the identification of MHC/T cell receptor (TCR) contact residues. The occurrence of intrinsic T cell reactivity to the self-antigen Abeta in humans has implications for the design of Abeta vaccines, may itself be linked to AD susceptibility and course, and appears to be associated with the aging process.

Citing Articles

Novel co-culture model of T cells and midbrain organoids for investigating neurodegeneration in Parkinson's disease.

Gerasimova E, Beenen A, Kachkin D, Regensburger M, Zundler S, Blumenthal D NPJ Parkinsons Dis. 2025; 11(1):36.

PMID: 40021643 PMC: 11871142. DOI: 10.1038/s41531-025-00882-8.

Peripheral and central neuroimmune mechanisms in Alzheimer's disease pathogenesis.

Zhang S, Gao Y, Zhao Y, Huang T, Zheng Q, Wang X Mol Neurodegener. 2025; 20(1):22.

PMID: 39985073 PMC: 11846304. DOI: 10.1186/s13024-025-00812-5.

Treatment of Alzheimer's Disease subjects with expanded non-genetically modified autologous natural killer cells (SNK01): a phase I study.

Zuniga C, Acosta B, Menchaca R, Amescua C, Hong S, Hui L Alzheimers Res Ther. 2025; 17(1):40.

PMID: 39939891 PMC: 11817217. DOI: 10.1186/s13195-025-01681-2.

The neuroimmune connectome in health and disease.

Wheeler M, Quintana F Nature. 2025; 638(8050):333-342.

PMID: 39939792 DOI: 10.1038/s41586-024-08474-x.

Exploring the role of T cells in Alzheimer's and other neurodegenerative diseases: Emerging therapeutic insights from the T Cells in the Brain symposium.

Elyaman W, Stern L, Jiang N, Dressman D, Bradley P, Klatzmann D Alzheimers Dement. 2025; 21(2):e14548.

PMID: 39868844 PMC: 11851166. DOI: 10.1002/alz.14548.

References

Teitelbaum D, Meshorer A, Hirshfeld T, Arnon R, Sela M . Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide. Eur J Immunol. 1971; 1(4):242-8. DOI: 10.1002/eji.1830010406. View

Scheinecker C, McHugh R, Shevach E, Germain R . Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J Exp Med. 2002; 196(8):1079-90. PMC: 2194046. DOI: 10.1084/jem.20020991. View

Cohen I . Antigenic mimicry, clonal selection and autoimmunity. J Autoimmun. 2001; 16(3):337-40. DOI: 10.1006/jaut.2000.0481. View

Togo T, Akiyama H, Iseki E, Kondo H, Ikeda K, Kato M . Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases. J Neuroimmunol. 2002; 124(1-2):83-92. DOI: 10.1016/s0165-5728(01)00496-9. View

Urbanc B, Cruz L, Le R, Sanders J, Ashe K, Duff K . Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease. Proc Natl Acad Sci U S A. 2002; 99(22):13990-5. PMC: 137824. DOI: 10.1073/pnas.222433299. View

Haas J, Storch-Hagenlocher B, Biessmann A, Wildemann B . Inducible nitric oxide synthase and argininosuccinate synthetase: co-induction in brain tissue of patients with Alzheimer's dementia and following stimulation with beta-amyloid 1-42 in vitro. Neurosci Lett. 2002; 322(2):121-5. DOI: 10.1016/s0304-3940(02)00095-2. View

Pfeifer M, Boncristiano S, Bondolfi L, Stalder A, Deller T, Staufenbiel M . Cerebral hemorrhage after passive anti-Abeta immunotherapy. Science. 2002; 298(5597):1379. DOI: 10.1126/science.1078259. View

Lue L, Rydel R, Brigham E, Yang L, Hampel H, Murphy Jr G . Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia. 2001; 35(1):72-9. DOI: 10.1002/glia.1072. View

Kawahata K, Misaki Y, Yamauchi M, Tsunekawa S, Setoguchi K, Miyazaki J . Generation of CD4(+)CD25(+) regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression. J Immunol. 2002; 168(9):4399-405. DOI: 10.4049/jimmunol.168.9.4399. View

10.

Furlan R, Brambilla E, Sanvito F, Roccatagliata L, Olivieri S, Bergami A . Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice. Brain. 2003; 126(Pt 2):285-91. DOI: 10.1093/brain/awg031. View

11.

Becher B, Prat A, Antel J . Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia. 2000; 29(4):293-304. View

12.

Grubeck-Loebenstein B, Wick G . The aging of the immune system. Adv Immunol. 2002; 80:243-84. DOI: 10.1016/s0065-2776(02)80017-7. View

13.

Kitani A, Chua K, Nakamura K, Strober W . Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells. J Immunol. 2000; 165(2):691-702. DOI: 10.4049/jimmunol.165.2.691. View

14.

Bard F, Cannon C, Barbour R, Burke R, Games D, Grajeda H . Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med. 2000; 6(8):916-9. DOI: 10.1038/78682. View

15.

Price D, Sisodia S . Mutant genes in familial Alzheimer's disease and transgenic models. Annu Rev Neurosci. 1998; 21:479-505. DOI: 10.1146/annurev.neuro.21.1.479. View

16.

Apostolou I, Sarukhan A, Klein L, von Boehmer H . Origin of regulatory T cells with known specificity for antigen. Nat Immunol. 2002; 3(8):756-63. DOI: 10.1038/ni816. View

17.

Hickey W . Basic principles of immunological surveillance of the normal central nervous system. Glia. 2001; 36(2):118-24. DOI: 10.1002/glia.1101. View

18.

Gaskin F, Finley J, Fang Q, Xu S, Fu S . Human antibodies reactive with beta-amyloid protein in Alzheimer's disease. J Exp Med. 1993; 177(4):1181-6. PMC: 2190957. DOI: 10.1084/jem.177.4.1181. View

19.

Bansal-Pakala P, Croft M . Defective T cell priming associated with aging can be rescued by signaling through 4-1BB (CD137). J Immunol. 2002; 169(9):5005-9. DOI: 10.4049/jimmunol.169.9.5005. View

20.

Mor F, Quintana F, Mimran A, Cohen I . Autoimmune encephalomyelitis and uveitis induced by T cell immunity to self beta-synuclein. J Immunol. 2002; 170(1):628-34. DOI: 10.4049/jimmunol.170.1.628. View